Sick of the variant propaganda. If it’s both more deadly and easier to spread, it’s man-made. In the ancient days of yore, I was taught that a bacteria/virus could do one of two things- increase lethality or change mode of transmission. Biologically it is too costly to do both so you don’t get airborne Ebola naturally in one leap. That said, viruses are tricky buggers.
We know that something can swap genetic materials to make it immune to a drug or other twists. The good news, our immune system is capable of seeing enough of the original to mount an attack based on previous exposure. These variants are allegedly 99% similar to the original SARS CV2; that means if the CV shot were effective, they would still work. (LOL) Those who have had CV are immune to variants. The average person had a >90% probability of having coronavirus antibodies/antigens from normal flu, etc to start with. Then there’s the Singaporean Study-
The team tested subjects who recovered from COVID-19 and found the presence of SARS-CoV-2-specific T cells in all of them, which suggests that T cells play an important role in this infection. Importantly, the team showed that patients who recovered from SARS 17 years ago after the 2003 outbreak, still possess virus-specific memory T cells and displayed cross-immunity to SARS-CoV-2.
“Our team also tested uninfected healthy individuals and found SARS-CoV-2-specific T cells in more than 50 percent of them. This could be due to cross-reactive immunity obtained from exposure to other coronaviruses, such as those causing the common cold, or presently unknown animal coronaviruses. It is important to understand if this could explain why some individuals are able to better control the infection,” said Professor Antonio Bertoletti, from Duke-NUS’ Emerging Infectious Diseases (EID) programme, who is the corresponding author of this study.
https://www.duke-nus.edu.sg/allnews/sars-cov-2-specific-t-cell-immunity-in-recovered-patients-and-uninfected-individuals
17 years later those who had original SARS most still had T-cells for it. So what is the point of wringing your hands over variants? Just the latest BS.
Regarding what's next in the boogeyman bio-weapons closet...I will give you a piece to chew on.
1998 Soviet defector Dr. K Alibek said they were working on things like a blend between smallpox and ebola. There you would have easy airborne transmissibility with increased lethality. The Soviets had already experiment with airborne anthrax with "great results."
https://arstechnica.com/science/2016/11/decades-after-deadly-lab-accident-a-secret-russian-bioweapon-decoded/
Here's an NPR transcript from 1998 w Alibek discussing bio-weapons.
http://www.nonproliferation.org/wp-content/uploads/npr/alibek63.pdf
Today's American Angle-
Back in 2000's when Ebola was breaking free in DRC, a company founded by virologist Nathan Wolfe called Metabiota discovered the Bas- Congo Virus in 2009. Odd little bug as you will read.
https://www.sciencedirect.com/science/article/pii/B9780124169753000029
Bas-Congo Virus: A Novel Rhabdovirus Associated With Acute Hemorrhagic Fever GildaGrard1JosephFair2CharlesChiu345EricLeroy16
In 2009, an outbreak of three cases of acute
hemorrhagic fever occurred in the Bas-Congo province of Democratic Republic of the Congo. The clinical presentation included abrupt onset of disease, fever, mucosal and gastrointestinal hemorrhages, and death within 3 days for the first two cases. The single serum sample was collected from the lone survivor, the nurse who cared for them. Since laboratory tests for all known viral hemorrhagic fever viruses in Central Africa were negative, extracted RNA from the serum sample were retrospectively analyzed by
next-generation sequencing, leading to the discovery and whole-genome assembly of a new
rhabdovirus, named Bas-Congo virus (BASV). BASV is highly divergent from other known rhabdoviruses, and is phylogenetically related to the dipteran-mammal-associated rhabdovirus supergroup. Specific
neutralizing antibodies were detected in the convalescent serum of the survivor and an asymptomatic close contact. Although the source of infection and mode of transmission for BASV have not yet been established,
phylogenetic and epidemiologic data suggest potential arthropod-borne transmission with nosocomial spread between humans.
It was never seen before nor has it ever been since. Looks and acts like rabies as for shape and multiplication time. Highly lethal
2009, they developed a computer program to decode the RNA of viruses, etc. that reduced diagnostic time to mere hours. Headed by USCSF's Dr. Chiu for Metabiota. Allegedly that's how they isolated Base Congo.
Computer program
https://pubmed.ncbi.nlm.nih.gov/12089242/
Abstract
Deep sequencing was used to discover a novel rhabdovirus (Bas-Congo virus, or BASV) associated with a 2009 outbreak of 3 human cases of acute hemorrhagic fever in Mangala village, Democratic Republic of Congo (DRC), Africa. The cases, presenting over a 3-week period, were characterized by abrupt disease onset, high fever, mucosal hemorrhage, and, in two patients, death within 3 days. BASV was detected in an acute serum sample from the lone survivor at a concentration of 1.09×106 RNA copies/mL, and 98.2% of the genome was subsequently de novo assembled from ∼140 million sequence reads. Phylogenetic analysis revealed that BASV is highly divergent and shares less than 34% amino acid identity with any other rhabdovirus. High convalescent neutralizing antibody titers of >1∶1000 were detected in the survivor and an asymptomatic nurse directly caring for him, both of whom were health care workers, suggesting the potential for human-to-human transmission of BASV. The natural animal reservoir host or arthropod vector and precise mode of transmission for the virus remain unclear. BASV is an emerging human pathogen associated with acute hemorrhagic fever in Africa.
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002924
This technology has not been used (to our knowledge) on the Ebola cases coming to the USA or on CV19. Why? Wouldn't that be more accurate than a PCR?
Wolfe started two companies Global Viral and Metabiota. GV was non-profit and M was for profit advising governments how to handle pandemics.
https://www.globalviral.org/nathan-wolfe
https://metabiota.com
Wolfe was young and charismatic, but many said he lacked knowledge and academic standing. Many in the science community said he didn't have any credible published research.( Front man?) Remember seeing a list of grant contributors to them: DARPA, USAMRID, City of London, GOOGLE,...usual suspects. Seems there's links to bioweapon development.
https://seemorerocks.is/documentary-proof-of-the-pentagons-massive-bioweapons-program-that-just-hit-america/
When the SF golden business M was sent to handle Sierre-Leone's Ebola outbreak, it was bedlam. All talk and incoherent actions.
https://www.cbsnews.com/news/american-company-metabiota-problems-during-ebola-outbreak/
Remember that the US govt. has patented an Ebola vaccine that uses rabies as the base.
https://academic.oup.com/jid/article/220/9/1521/5543203
Could this be the reason that airlines are flying migrants for free from Ebola heavy areas in Africa into the USA from 2019? Was the previous USA spotty outbreak with the Dallas case a test run?
https://www.ebolaoutbreakmap.com/listings/free-flights-for-congo-african-migrants/
Just saying...CV may be a cake walk with these other things up their sleeves.